This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O’Donnell, C. P. F.
Right arrow Articles by Morley, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O’Donnell, C. P. F.
Right arrow Articles by Morley, C. J.
Related Collections
Right arrow Therapeutics & Toxicology
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 110 No. 5 November 2002, pp. e52

ELECTRONIC ARTICLE

Unlicensed and Off-Label Drug Use in an Australian Neonatal Intensive Care Unit

Colm P. F. O’Donnell, MRCPI, MRCPCH, Robyn J. Stone, BPharm, Clin Pharm and Colin J. Morley, DCH, MD, FRCP, FRCPCH, FRACP

From the Neonatal Unit, Royal Women’s Hospital, Victoria, Australia

--> Objectives. To determine the extent of unlicensed and off-label drugs prescribed in the level 3 neonatal intensive care unit (NICU) at the Royal Women’s Hospital, Melbourne, Australia.

Methods. A prospective cohort study was conducted of all infants who were admitted to the NICU during a 10-week period. Each drug prescribed was evaluated in relation to the licensed approved uses to determine whether the drug was administered in a licensed manner or was unlicensed or used in an off-label manner.

Results. There were a total of 101 admissions involving 97 infants. A total of 1442 prescriptions were administered; 42% were licensed, 11% were unlicensed, and 47% were off-label. Twenty-one percent were off-label for 2 or more reasons. Eighty percent of infants received either an unlicensed or an off-label prescription or both; this proportion rose to 93% of extremely low birth weight infants.

Conclusions. This is the largest study performed of unlicensed and off-label drug use in the NICU. This practice remains widespread despite clear recommendations to improve this undesirable situation. The attendant risks to infants and prescribers remain. It is time for legislation to be introduced to govern this area.

Key Words: neonates • unlicensed drugs • off-label drugs

Abbreviations: NICU, neonatal intensive care unit

Received for publication Apr 29, 2002; Accepted Jul 29, 2002.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Eur Respir JHome page
A. Bush
Evidence-based medicines for children: important implications for new therapies at all ages
Eur. Respir. J., December 1, 2006; 28(6): 1069 - 1072.
[Full Text] [PDF]

Home page
 BMJHome page
H. Marcovitch
Safer prescribing for children
BMJ, September 24, 2005; 331(7518): 646 - 647.
[Full Text] [PDF]